GYLDEN PHARMA LIMITED
Company number 09955881 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£61,596,965
Balance sheet as at 2025-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2016-01-18
- Employees
- 36 (2025 accounts · was 39 in 2024)
- Registered office
- 4 & 5 Dunmore Court Wootton Road, Abingdon, Oxfordshire, England, OX13 6BH
- Postcode
- OX13 6BH
- Capital
- 45 GBP
- Accounts category
- Unaudited Abridged
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-08-07
- Next due by
- 2027-08-21
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 6 current · 12 resigned
Group structure 3 subsidiaries
-
BARSOOM LIMITED Dissolved
-
EMERGEX VACCINES LIMITED Dissolved
-
GYLDEN LIMITED Dissolved
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Contact details
- Website
- emergexvaccines.com
Previous company names
| Name | Date changed |
|---|---|
| EMERGEX VACCINES HOLDING LIMITED | 2024-10-16 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| C/O BUCKWORTHS, 26 CURTAIN ROAD, LONDON, EC2A 3NY, UNITED KINGDOM | 2016-02-03 |
At this address
Among the biggest employers
of 118 similar companies in OX, with 36 staff.
Competitors Oxford
This company ranks 177 among research and experimental development on biotechnology in Oxford.
The class of 2016
36%
of the 402 companies in this sector incorporated in 2016 are still active today; 59% have since been dissolved.
A fact about the year, not a forecast for this company.